The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)S protein inhibits inflammatory responses of alveolar epithelial type II cells during the early stages of infections by activating the PI3K/AKT pathway (32). The gene discussed is AKT1; the disease is infection.